Anticancer Drug articles & resources on Made-in-China.com

TCM Unleashes Hidden Potential

Dec 8, 2015

Eighty-four-year-old Tu Youyou arrived in Sweden on Friday to collect China's first Nobel Prize in medicine for creating an anti-malarial drug that saved millions of people across the world. Half a century ago, the pharmacologist derived ...

Tags: Traditional Chinese Medicine, medicine

Veeco Receives R&D 100 Award for its SPECTOR-HT Ion Beam Deposition (IBD) System

Jul 12, 2013

Veeco has received an R&D 100 Award for its SPECTOR-HT Ion Beam Deposition (IBD) System. Initiated in 1962 and called the "Oscars of Innovation," the R&D Awards, issued by R&D Magazine, recognize and celebrate the top 100 technology ...

Tags: Lights, Lighting

Incanthera Has Launched a Partnership with Global Investment Group Technomark Life Science

Feb 18, 2013

Leading oncology company Incanthera has launched a partnership with global investment group Technomark Life Sciences. The two businesses will work together to prepare ICT2588 - Incanthera’s revolutionary treatment for solid tumours ...

Tags: Life Sciences, clinical trials, medical

US Patent and Trademark Office Has Issued a Patent for Lorus Therapeutics's LOR-253

Dec 7, 2012

The United States Patent and Trademark Office has issued a patent for Lorus Therapeutics' LOR-253, which covers composition of matter and methods of treating cancer. The patent was initially set to expire in May 2026 and latter was ...

Tags: LOR-253, small molecule anticancer drug, Lorus

ACT Received Phase I SBIR Grant of $158,000 From NIH to Support Drug Development

Nov 28, 2012

Advanced Cancer Therapeutics (ACT) has received Phase I small business innovative research (SBIR) grant of $158,000 from the National Cancer Institute of the National Institutes of Health (NIH) to support the development of an anti cancer ...

Tags: ACT, SBIR Grant, anti cancer drug, Anticancer Drug

Lorus Therapeutics Receives First Japanese Patent for Anticancer Drug LOR-253

Aug 15, 2012

Lorus Therapeutics has received first Japanese patent for its small molecule anticancer drug LOR-253 that will provide Lorus with exclusive rights to LOR-253 in Japan until 2023. The patent will provide protection for LOR-253 composition ...

Tags: patent, anticancer drug, pharmaceutical product

Anticancer Drug